Vifor Pharma, a Swiss global specialty pharmaceutical company, has named Stefan Schulze as its new CEO effective 14 May 2020, it was reported on Thursday.
Presently, Schulze has been the president of the Executive Committee and chief operating officer since 2017.
Schulze, an engineer by education, spent his professional career in the healthcare industry in the United States and Europe. He was working for the Fresenius Group in various positions from 1992 to 2014. In 2014 he became CEO of Vifor Fresenius Medical Care Renal Pharma.
SportsMed Physical Therapy named Physical Therapy Company of the Year
Ensorcell adds new senior leadership team members
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
OncoHost receives BIG Innovation Award in Health category
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership